戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              STS and 17beta-HSD1 are attractive targets for the treat
2                                              STS measures demonstrated poor repeatability, but the av
3                                              STS programs that voluntarily participate in public repo
4                                              STS public reporting participation varied from 22.2% to
5                                              STS public reporting sites had higher mean annualized co
6                                              STS results clearly illustrate the opening of an insulat
7                                              STS results show the surface Fermi level remains unpinne
8                                              STS score tended to be lower in the new-generation devic
9                                              STS score, resting left ventricular ejection fraction, m
10                                              STS-E412 also increased phosphorylation of EPOR, CD131,
11                                              STS-E412 triggered EPO receptor phosphorylation in human
12                                             (STS/ACC Transcatheter Valve Therapy Registry [TVT Regist
13 illation (1.41; 95% CI, 1.06-1.87; P = .02), STS score (1.03; 95% CI, 1.01-1.06; P = .02), presence o
14 929 unique observations ( approximately 1000 STS participant centers, 9 reporting periods), 916 sites
15 pace Transportation System (STS)-131 (n=11), STS-133 (n=6), and STS-135 (n=3) shuttle missions and re
16  commonly exceeded 25 miles: HCAHPS (39.2%), STS-CABG (62.7%), and US News Top Hospital (85.2%).
17 .Hospitals were rated for HCAHPS (n = 4656), STS-CABG (n = 470), and US News Top Hospitals (n = 15).
18  of the STS and CHS gene families yielded 48 STS genes, including at least 32 potentially functional
19 emoral access (HR, 1.37; 95% CI, 1.27-1.48), STS PROM score greater than 15% vs less than 8% (HR, 1.8
20  exceeded 25 miles commonly: HCAHPS (23.7%), STS-CABG (36.7%), US News Top Hospitals (81.8%).Signific
21 they may explain why some patients develop a STS at the site of injury.
22 other first-line chemotherapies for advanced STS.
23                                  In advanced STS, PFS and RR seem to be appropriate surrogates for OS
24 orubicin as first-line treatment of advanced STS patients.
25 in alone as first-line treatment of advanced STS.
26 dcare was linked with the degree of amygdala-STS connectivity.
27 antation, 383 (202 TAVR and 181 SAVR) had an STS PROM of 7% or less (median [interquartile range]: TA
28 ho underwent an attempted implant and had an STS PROM of 7% or less.
29                  These results illuminate an STS network involved in processes associated with multip
30 e-in-ring procedures were high risk, with an STS PROM for mitral valve replacement of 11%.
31 iomyopathy Questionnaire in patients with an STS PROM score of 7% or less.
32 Space Shuttle Atlantis missions: STS-132 and STS-135, and the biofilms formed during spaceflight were
33  System (STS)-131 (n=11), STS-133 (n=6), and STS-135 (n=3) shuttle missions and respective ground-bas
34 functional connectivity between amygdala and STS.
35  Home-visiting programs, MDS-HF clinics, and STS interventions produced a mortality benefit.
36  with the Pentacam and BioGraph devices) and STS (measured with the HiScan device) were estimated.
37 ta-converting enzymes in response to Dox and STS.
38 rcinomas observed in 79% of the females, and STS observed in 27% of the patients.
39 e activation than naming in both SII/OP1 and STS bilaterally.
40 The tradeoff between activity in SII/OP1 and STS was not observed during reading, which showed signif
41 ther metastatic cancer cells tested, RCC and STS cells exhibited increased levels of expression of fi
42  putative sCSCs, autologous bone sarcoma and STS cells were engineered with a CSC detector vector enc
43 K) cells against autologous bone sarcoma and STS, including against putative sCSCs.
44 eractions were prominent in both the STP and STS.
45 ge interdevice bias was observed for WTW and STS measures.
46 th Si-H termination as confirmed by XPS, and STS results confirm the saturated Si-Hx bilayer leaves t
47 ies or objects) in the rpSTS, right anterior STS (raSTS), and right amygdala, compared with TBS deliv
48 ies or objects, in the rpSTS, right anterior STS (raSTS), and right amygdala.
49             As one of our examples, we apply STS to check nonclassical correlations among sites in a
50 r low-grade tumors, for radiation-associated STS, and for survival benefit.
51 cic Surgeons/American College of Cardiology (STS/ACC) Transcatheter Valve Therapies Registry were lin
52 e movement types requires access to a common STS network and that individual network nodes are recrui
53 characterization of the nonpeptidyl compound STS-E412 (2-[2-(4-chlorophenoxy)ethoxy]-5,7-dimethyl-[1,
54             At low nanomolar concentrations, STS-E412 provided EPO-like cytoprotective effects in pri
55 gration) or right (due to emotional content) STS.
56 apped with phloem enzymes along the cucurbit STS.
57  Space Transportation System (STS)-131, 13-d STS-135, and 30-d Bion-M1 missions.
58  Surgeons Congenital Heart Surgery Database (STS-CHSD) will begin voluntary public reporting of progr
59 r results also reveal an area in dorsomedial STS that is modulated almost exclusively by vergence mov
60  a vergence-specific area within dorsomedial STS.
61 ropriate for preoperative IGRT for extremity STS.
62 atients with primary nonmetastatic extremity STS were treated with limb-sparing surgery and adjuvant
63 f late toxicities in patients with extremity STS who were treated with preoperative IGRT and absence
64 D) and TP53 (R167H) transgenes, allowing for STS modeling in a spatial and temporal manner.
65 AHPS hospital (89.6%), but less commonly for STS-CABG (62.9%).
66  There exists a characteristic frequency for STS power dissipation, CFSTS, defined as the frequency w
67 ts in adjuvant treatment recommendations for STS.
68 les of neoadjuvant chemotherapy with RHT for STS.
69 les of neoadjuvant chemotherapy plus RHT for STS.
70                                    Mice from STS missions were euthanized within 4 h after landing, w
71 est convergent evolution of plant and fungal STSs, and also indicate that the colocalized PT-TPS gene
72 te of 50%, highlighting the need for further STS research.
73  we show that HIF-2alpha inhibits high-grade STS cell growth in vivo, as loss of HIF-2alpha promotes
74  rating for coronary artery bypass grafting (STS-CABG), and Centers for Medicare and Medicaid Service
75  multivariable Cox survival analysis, higher STS score (hazard ratio [HR]: 1.14), more abnormal resti
76  women and had more comorbidities and higher STS mortality risk scores.
77 n the horizontal WTW measures and horizontal STS estimates when bias was accounted for was small ghe,
78  WTW measures were wider than the horizontal STS measures (bias >0.91 mm, P < .01).
79 a) RNA-seq data to compare Oncopig and human STS expression profiles.
80 l models representative of the diverse human STS subtypes critical.
81 oter was hypermethylated frequently in human STS.
82 e Oncopig STS model's ability to mimic human STS transcriptional profiles, providing a valuable resou
83                      We find that most human STS have lower levels of EPAS1 (the gene encoding HIF-2a
84           Transcriptional hallmarks of human STS were observed in Oncopig STS, including altered TP53
85 s previously identified as a potential human STS therapeutic target.
86 4 expression in established murine and human STSs decreased tumor volume by almost two-thirds and cel
87 ses as early in the auditory hierarchy as in STS are more correlated with semantic than spectral repr
88 ha as a biomarker for Vorinostat efficacy in STS.
89 ral vocal features, which was not evident in STS units.
90 ystematic review of systemic therapy RCTs in STS was performed.
91 omas (STSs) to determine NG2/CSPG4's role in STS initiation and growth.
92 ulatory and semantic in STS, and semantic in STS and beyond.
93 TG, mixtures of articulatory and semantic in STS, and semantic in STS and beyond.
94                      Many cancers, including STS, contain altered epigenetics, and our findings defin
95             Institutional STS data including STS predicted risk of postoperative stroke score were us
96  grapevine hairy roots resulted in increased STS expression and in the accumulation of glycosylated s
97          Drugs have been designed to inhibit STS, e.g., Irosustat, as innovative dual-targeting aroma
98                          Vorinostat inhibits STS tumour growth, an effect ameliorated by HIF-2alpha d
99                                Institutional STS data including STS predicted risk of postoperative s
100                               Interestingly, STS exerted its metabolic benefit through sex-specific m
101                            To our knowledge, STS-E412 is the first nonpeptidyl, selective activator o
102                      In fungi, all six known STSs are bifunctional, containing C-terminal trans-preny
103 ity in the left superior temporal sulcus (L. STS), a key site for the integration of real audiovisual
104 reased effective connectivity between the L. STS and the auditory cortex.
105 (cv PN40024) has revealed an unusually large STS gene family.
106 auditory+unimodal visual]) responses in left STS to crossmodal speech stimuli.
107 n showed a role for right (rather than left) STS.
108   Deletion or point mutation of the X-linked STS gene, encoding the enzyme steroid sulfatase (STS) in
109                The metabolic benefit in male STS transgenic mice was retained after castration.
110                                         Mean STS score was 3.98 +/- 1%; 54% of patients were in New Y
111                                         Mean STS score was 5.5% +/- 8%, and mean LVEF was 57 +/- 4%,
112          A total of 331 patients with a mean STS score of 6.7 +/- 6.7 underwent TAVR.
113 iple comorbidities, reflected by a high mean STS predicted risk of mortality (STS PROM) for surgical
114 istics (age, 79+/-8.2 years; 60% women; mean STS [Society of Thoracic Surgery] score 8.1+/-5.5%).
115 s 84 years and 52% were women, with a median STS Predicted Risk of Operative Mortality (STS PROM) sco
116 ly stratified patients by the overall median STS PROM score (7%) and analyzed clinical outcomes and q
117 783 patients (49%) were women and the median STS predicted risk of mortality was 7% (IQR, 5%-11%).
118                              In female mice, STS may have increased hepatic estrogen activity by conv
119  during two Space Shuttle Atlantis missions: STS-132 and STS-135, and the biofilms formed during spac
120 evels <3.3 g/dl, falls in the past 6 months, STS PROM score >7%, and severe (>/=5) Charlson comorbidi
121 oracic Surgeons Predicted Risk of Mortality (STS PROM) alone is sufficient to define decreased risk,
122 a high mean STS predicted risk of mortality (STS PROM) for surgical valve replacement (8.34%), were h
123 oracic Surgeons Predicted Risk of Mortality (STS PROM) has trended downward in US TAVR trials and the
124 oracic Surgeons Predicted Risk of Mortality (STS PROM), and subjective criteria to assess patients' e
125 oracic Surgeons Predicted Risk of Mortality (STS-PROM) (<4% versus >/=4%), there was no statistically
126 expected risk of 30-day operative mortality (STS Predicted Risk of Mortality [PROM]) of 7% to 6% and
127 n STS Predicted Risk of Operative Mortality (STS PROM) score of 7.1%.
128 reduced all-cause readmission and mortality; STS reduced HF-specific readmission and mortality.
129 ghlights the importance of multidisciplinary STS tumor boards and interdisciplinary care to facilitat
130 but not HIF-1alpha, accumulation in multiple STS subtypes.
131 o the generally assumed shear flow, nonshear STS flow patterns were simulated.
132        In contrast, the metabolic benefit of STS in males may have been accounted for by the male-spe
133 y is an unusual but not rare complication of STS sclerotherapy.
134 umber of STS subtypes, making development of STS cell lines and animal models representative of the d
135 r results have uncovered a novel function of STS in energy metabolism and type 2 diabetes.
136 egarding the multidisciplinary management of STS were scored on a 5-point Likert scale and analyzed u
137       We recently described a mouse model of STS whereby p53 is deleted and oncogenic Kras is activat
138 ll line availability and the large number of STS subtypes, making development of STS cell lines and a
139 ic disease, we showed that overexpression of STS in the liver of transgenic mice alleviated HFD and o
140       Further evaluation of the potential of STS-E412 in central nervous system diseases and organ pr
141 ed to specifically activate the promoters of STS genes, and the ectopic expression of MYB15 in grapev
142      In defining the functional relevance of STS induction in metabolic disease, we showed that overe
143 visual influences modulated the responses of STS neurons with greater specificity and were more often
144                  The receptor selectivity of STS-E412 was confirmed by a lack of phosphorylation of t
145                    The repeatability (Sr) of STS measured with the HiScan was 0.39 mm, which was sign
146         So far only a very limited number of STSs have been characterized.
147 60 and 7,652 genes was identified in Oncopig STS cell lines and leiomyosarcomas, respectively.
148 lmarks of human STS were observed in Oncopig STS, including altered TP53 signaling, Wnt signaling act
149    Furthermore, master regulators of Oncopig STS expression were identified, including FOSL1, which w
150        These results demonstrate the Oncopig STS model's ability to mimic human STS transcriptional p
151                  This study utilized Oncopig STS cell line (fibroblast) and tumor (leiomyosarcoma) RN
152                 Mutation of this site in one STS (AtTPS19) resulted in premature termination of carbo
153 nificant differences in preoperative risk or STS predicted risk of mortality between groups.
154 m those catalyzed by the characterized plant STSs by forming unified 15/5 bicyclic sesterterpene inte
155             The discovery of three new plant STSs is reported that produce a suite of sesterterpenes
156 ard medical therapy or standard therapy plus STS injection (80 mg, once daily for 14 consecutive days
157 ered over the face-selective right posterior STS (rpSTS) or over the vertex control site.
158 activated a distinct region in the posterior STS, close to-albeit not overlapping with-the medial fac
159                                 Preoperative STS predicted risk of postoperative stroke scores were n
160  compared with conventional EBRT for primary STS of the extremity.
161 er tissue injury in a mouse model of primary STS, and they may explain why some patients develop a ST
162 riptional responses to hypoxia, and promotes STS metastasis; however, the role of the related HIF-2al
163 of these as primary end points in randomized STS trials.
164                         Our locally resolved STS indicated considerable finite conductance on all sur
165 ra-additive responses were observed in right STS within the first 250 ms for emotionally incongruent
166  which further underscores the role of right STS in processing crossmodal emotive signals.
167 s III/IV), and at prohibitive surgical risk (STS score: 13.2 +/- 7.3%).
168 iteria in patients with soft-tissue sarcoma (STS) after combined chemotherapy plus regional hyperther
169 rolled trials (RCTs) in soft tissue sarcoma (STS) have used varying end points.
170 ciplinary management of soft tissue sarcoma (STS) of the extremities, controversy exists regarding ad
171 RT) in the treatment of soft tissue sarcoma (STS) of the extremity is increasing, but no large-scale
172      Some patients with soft-tissue sarcoma (STS) report a history of injury at the site of their tum
173 ith first-line advanced soft tissue sarcoma (STS) to assess progression-free survival (PFS), response
174 patients with extremity soft tissue sarcoma (STS) treated with preoperative image-guided radiation th
175 18 canine patients with soft tissue sarcoma (STS), CIVO captured complex, patient-specific tumor resp
176 ell carcinoma (RCC) and soft tissue sarcoma (STS), have an inherent capacity to generate extensive in
177 survival in adults with soft tissue sarcoma (STS).
178  in high-risk extremity soft tissue sarcoma (STS).
179 high-risk nonmetastatic soft tissue sarcoma (STS).
180 sidered active drugs in soft tissue sarcoma (STS).
181 tatic bone sarcoma and soft-tissue sarcomas (STS) are incurable due to the inability to eradicate che
182                  Human soft-tissue sarcomas (STS) are rare mesenchymal tumors with a 5-year survival
183 (ACC), CNS tumors, and soft tissue sarcomas (STS) observed in 30%, 27%, 26%, and 23% of the patients,
184                     In soft tissue sarcomas (STS), low intratumoural O2 (hypoxia) is a poor prognosti
185 thonous mouse model of soft-tissue sarcomas (STSs) to determine NG2/CSPG4's role in STS initiation an
186 f brain connectivity between voice-selective STS and reward, affective, salience, memory, and face-pr
187                                   Similarly, STS stimulated robust IL-1beta processing and release in
188 the "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of P
189 dles are situated in the subtectorial space (STS)--a micrometer-thick space between two flat surfaces
190                               Liver-specific STS induction or estrogen/estrogen sulfate delivery may
191 nning tunneling microscopy and spectroscopy (STS) measurements on the "Kondo insulator" SmB6.
192 y (STM) and scanning tunneling spectroscopy (STS) measurements, as well as computational simulations
193 ified using scanning tunneling spectroscopy (STS).
194 y means of scanning tunnelling spectroscopy (STS), as well as the two-particle exciton transition ene
195 (EIS), and scanning tunnelling spectroscopy (STS).
196 es, the USDA Forest Service Slow the Spread (STS) programme for managing the future spread of gypsy m
197 A) and adenosine, promoted by staurosporine (STS), reduced in hearts lacking PLM, and correlates with
198  such as doxorubicin (Dox) or staurosporine (STS).
199 uce the concept of spatio-temporal steering (STS), which reduces, in special cases, to Einstein-Podol
200  regions across the (right) mid-anterior STG/STS (speakers) and bilateral mid-posterior STG/STS (vowe
201 S (speakers) and bilateral mid-posterior STG/STS (vowels), as well as the superior temporal plane inc
202 he right superior temporal gyrus/sulcus (STG/STS) during speaker categorization and in the right post
203 g tunneling microscopy and spectroscopy (STM/STS), photoemission electron microscopy/spectroscopy (PE
204  lower bank of the superior temporal sulcus (STS) and neighboring regions of IT cortex.
205  cortex (ACC), and superior temporal sulcus (STS) are linked to basic social cognitive processes comm
206 high activation of superior temporal sulcus (STS) comparable to SC-Fathers, and functional connectivi
207 monkeys to map the superior temporal sulcus (STS) for BOLD modulation associated with visually guided
208 p of the posterior superior temporal sulcus (STS) in area TEO, and an anterior curvature-biased patch
209 l pathway from the superior temporal sulcus (STS) projecting into dorsal subregions of the amygdala,
210           However, superior temporal sulcus (STS) regions have recently been reported to represent au
211 egion in the right superior temporal sulcus (STS) that lies within the auditory cortex, and is activa
212 ral regions of the superior temporal sulcus (STS) whose responses varied with segment length.
213 ical volume in the superior temporal sulcus (STS), a region implicated in schizophrenia.
214 in the neighboring superior temporal sulcus (STS).
215 x; voice-selective superior temporal sulcus (STS); the amygdala, which is crucial for processing of a
216 gene, encoding the enzyme steroid sulfatase (STS) influences risk for ADHD.
217  blocked by aromatase and steroid sulfatase (STS) inhibitors confirming intracrine synthesis to estro
218                       The steroid sulfatase (STS)-mediated desulfation is a critical metabolic mechan
219 e-dependent cancer target steroid sulfatase (STS).
220 ss of adjunct sodium tanshinone IIA sulfate (STS) therapy on circulating inflammation markers in CAD
221                Structured telephone support (STS) interventions reduced HF-specific readmission (high
222            The Society of Thoracic Surgeons (STS) and American College of Cardiology (ACC) transcathe
223 (ACCF) and the Society of Thoracic Surgeons (STS) collaborated to compare the rates of long-term surv
224 d according to Society of Thoracic Surgeons (STS) criteria as any confirmed neurological deficit of a
225 ipating in the Society of Thoracic Surgeons (STS) national database.
226 orded, and the Society of Thoracic Surgeons (STS) score was calculated.
227 e obtained and Society of Thoracic Surgeons (STS) score was calculated.
228 .1%) men; mean Society of Thoracic Surgeons (STS) score, 11.4% (4.0%); and mean LVSVI, 27.6 (5.0) mL/
229 iography data, Society of Thoracic Surgeons (STS) scores, and death were recorded in 737 patients (me
230            The Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter
231 6 sites in the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter
232            The Society of Thoracic Surgeons (STS)/American College of Cardiology Transcatheter Valve
233       As many of the sesquiterpene synthase (STS) genes encountered in nature are of plant origin and
234                      Sesterterpene synthase (STS)-mediated cyclization of the linear C25 isoprenoid p
235 INOSE SYNTHASE (RS), and STACHYOSE SYNTHASE (STS) are the enzymes responsible for RFO biosynthesis in
236 e ammonia-lyase (PAL) and stilbene synthase (STS) genes, followed by a rapid accumulation of E-resver
237 scaffold-generating sesterterpene synthases (STSs).
238                 Although stilbene synthases (STSs), the key enzymes responsible for resveratrol biosy
239                          Stilbene synthases (STSs), which catalyze the biosynthesis of the stilbene b
240 ce flown on the Space Transportation System (STS)-131 (n=11), STS-133 (n=6), and STS-135 (n=3) shuttl
241 es for the 15-d Space Transportation System (STS)-131, 13-d STS-135, and 30-d Bion-M1 missions.
242 of spaceflight [Space Transportation System (STS)-135 shuttle mission] enhances myogenic vasoconstric
243  other metabolites in the sieve tube system (STS) at specific sites along the pathway.
244                                          The STS programme annually deploys a grid of 60,000-100,000
245                                          The STS records were linked to Medicare files to allow longi
246                                          The STS trap data have also created a unique opportunity to
247  this regard, at various locations along the STS we could map metabolites and their related enzymes t
248 s trended downward in US TAVR trials and the STS/American College of Cardiology Transcatheter Valve T
249 o measures of this effect referred to as the STS weight and robustness.
250 re-biased patch (ACP) located just below the STS in anterior area TE.
251 urther suggest that connectivity between the STS and auditory cortex plays a modulatory role in spati
252 us friction, previous studies considered the STS as the primary place of energy dissipation in the co
253                                Mice from the STS-131 mission exhibited reduced myogenic (Myf5 and -6)
254                                Data from the STS/ACC TVT Registry have been used to develop a predict
255                 The power dissipation in the STS because of the presence IHC stereocilia increased as
256 y properties of action representation in the STS can directly be explained from the properties of nat
257                            Three SNPs in the STS gene (rs6639786, rs2270112, and rs17268988) and one
258 we investigated the power dissipation in the STS.
259  bundle reduced the power dissipation in the STS.
260 ergoing TAVR in centers participating in the STS/ACC TVT Registry from November 1, 2011, to February
261 atients undergoing TAVR at US centers in the STS/ACC TVT Registry, device implantation success was ac
262 ia bundle--the IHC stereocilia increased the STS power dissipation by 50- to 100-fold.
263                      Our reannotation of the STS and CHS gene families yielded 48 STS genes, includin
264 maps within and around the lower bank of the STS and extend these prior findings to scene-selective c
265 devices created through a partnership of the STS and the ACC in close collaboration with the Food and
266  Registry has been a joint initiative of the STS and the ACC in concert with multiple stakeholders.
267 discussed with regard to the function of the STS as a unique and highly complex metabolic space withi
268 itions, consistent with the operation of the STS as a unique symplasmic domain.
269 odel, or pharmacological manipulation of the STS axis, via administration of the enzyme substrate deh
270 the relationships among polymorphisms of the STS gene and SULT2A1 gene, dehydroepiandrosterone (DHEA)
271 ace patch in the anterior fundus (AF) of the STS while macaques freely view complex videos rich with
272 riction between the two flat surfaces of the STS.
273 uropil volume in the rodent homologue of the STS.
274 e (n = 8) to microgravity for 15-days on the STS-131 space shuttle mission.
275            When examined parametrically, the STS response increased with segment length up to approxi
276 S) with fMRI to test the prediction that the STS and amygdala are functionally connected during face
277  pharmacological evidence indicates that the STS axis is involved in inhibitory processes and can be
278                      Addition of RVSP to the STS score significantly reclassified the risk for longer
279                           Treatment with the STS substrate estrone sulfate also improved metabolic fu
280 e found the C allele of rs2270112 within the STS gene to be over-transmitted in males with ADHD.
281              Several visual areas within the STS of the macaque brain respond strongly to faces and o
282 long the source-sink pathway and between the STSs of these three cucurbits.
283 re at increased surgical risk based on their STS PROM score and other risk factors.
284 e of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry.
285 e of Cardiology Transcatheter Valve Therapy [STS/ACC TVT] Registry) was initiated to meet a condition
286 at on the basis of standard medical therapy, STS further reduce elevated hs-CRP and other circulating
287 ively correlated with pSTAT1 levels in these STS specimens.
288                        We suggest that these STS measures enable a new way to assess nonclassical cor
289 tum chemical calculations suggest that these STSs catalyze an unusual cyclization path involving repr
290 tion of predicted METs and resting LV-GLS to STS, resting RVSP, left ventricular end-systolic dimensi
291 ological pathogenesis of ADHD with regard to STS polymorphisms and neurosteroid levels.
292 rdiac surgery public reporting program using STS clinical registry data and National Quality Forum-en
293 itiatives have recently been published using STS-CHSD.
294     In contrast, we found that ventrolateral STS is driven preferentially during versional movements.
295  of pazopanib was performed in children with STS or other refractory solid tumors.
296 ted MYB14 and MYB15, strongly coexpress with STS genes, both in leaf tissues under biotic and abiotic
297 ], respectively; P > .99) and congruent with STS predicted risk of mortality.
298 vorably with SAVR in high-risk patients with STS PROM scores traditionally considered intermediate ri
299                            Ten patients with STS underwent dynamic contrast-enhanced magnetic resonan
300  Our results show that multiple areas within STS modulate during all movement types studied, includin

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top